|
|
|
Repligen Corp (NASDAQ: RGEN) |
|
RGEN's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Repligen Corp |
RGEN |
6,648 |
650 |
-23 |
1,800 |
| Thermo Fisher Scientific Inc |
TMO |
148,780 |
42,898 |
6,518 |
122,000 |
| Danaher Corporation |
DHR |
140,152 |
23,820 |
3,765 |
63,000 |
| Bio rad Laboratories Inc |
BIO |
6,486 |
2,541 |
-2,164 |
8,030 |
| Agilent Technologies inc |
A |
32,923 |
6,614 |
1,403 |
17,900 |
| Qiagen N v |
QGEN |
10,461 |
1,919 |
84 |
5,800 |
| Nanostring Technologies Inc |
NSTG |
5 |
162 |
-166 |
469 |
| Bio techne Corp |
TECH |
7,968 |
1,218 |
111 |
3,100 |
| Twist Bioscience Corporation |
TWST |
2,141 |
348 |
-191 |
923 |
|
SUBTOTAL |
355,563 |
80,171 |
9,335 |
223,022 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
